Literature DB >> 24807489

Mechanisms of pain from urinary tract infection.

John M Rosen1, David J Klumpp.   

Abstract

The pain response to urinary tract infection is largely uncharacterized, but the symptomatic response to urinary tract infection contrasts with the lack of pain response among individuals with asymptomatic bacteriuria. Quantifying pelvic pain in a murine urinary tract infection model, uropathogenic Escerichia coli induces transient pelvic pain, whereas an asymptomatic bacteriuria E. coli isolate causes no pain, thus recapitulating the spectrum of clinical responses to intravesical E. coli. These differential pain responses are not correlated with bladder colonization or inflammation, but instead are intrinsic to E. coli lipopolysaccharide and dependent on the lipopolysaccharide receptor, TLR4. Epidemiological data suggest a link between interstitial cystitis and a history of urinary tract infection, so it was evaluated whether repetitive uropathogenic E. coli instillation would result in chronic pain through central sensitization. Although repeated infection with wild type uropathogenic E. coli results in only transient episodes of acute pain, a uropathogenic E. coli mutant lacking O-antigen causes chronic, post-urinary tract infection pelvic pain. Similarly, a K-12 E. coli strain lacking O-antigen induces chronic pain that persisted long after bacterial clearance, and expressing O-antigen nullified the pain phenotype. Spinal cords isolated from mice with post-urinary tract infection chronic pain showed deficits in short-term depression consistent with central sensitization. Deleting O-antigen gene complex from a uropathogenic E. coli strain and subsequent heterologous expression of O-antigen gene clusters shows that a single bacterial isolate can exhibit pain phenotypes ranging from a null phenotype, an acute pain phenotype, to a chronic pain phenotype. Post-urinary tract infection chronic pain is also associated with voiding dysfunction and anxious/depressive behavior. These effects are also mediated by TRPV1 at the level of pain establishment and CCR2 at the level of pain maintenance. Together, these findings show that transient infection with E. coli might result in chronic visceral pain with the hallmarks of neuropathic pain. This pattern of behaviors mimics the spectrum of interstitial cystitis symptoms, thus supporting the possibility of an infectious etiology of interstitial cystitis.
© 2014 The Japanese Urological Association.

Entities:  

Keywords:  O-antigen; centralization; infection; lipopolysaccharide; pain

Mesh:

Substances:

Year:  2014        PMID: 24807489      PMCID: PMC4552327          DOI: 10.1111/iju.12309

Source DB:  PubMed          Journal:  Int J Urol        ISSN: 0919-8172            Impact factor:   3.369


  64 in total

Review 1.  Bacterial pili: molecular mechanisms of pathogenesis.

Authors:  F G Sauer; M A Mulvey; J D Schilling; J J Martinez; S J Hultgren
Journal:  Curr Opin Microbiol       Date:  2000-02       Impact factor: 7.934

Review 2.  Irritable bowel syndrome: methods, mechanisms, and pathophysiology. Neural and neuro-immune mechanisms of visceral hypersensitivity in irritable bowel syndrome.

Authors:  Bin Feng; Jun Ho La; Erica S Schwartz; G F Gebhart
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2012-03-08       Impact factor: 4.052

Review 3.  Tests and models of nociception and pain in rodents.

Authors:  M Barrot
Journal:  Neuroscience       Date:  2012-01-05       Impact factor: 3.590

4.  Intravesical resiniferatoxin for the treatment of interstitial cystitis: a randomized, double-blind, placebo controlled trial.

Authors:  Christopher K Payne; Philip G Mosbaugh; John B Forrest; Robert J Evans; Kristene E Whitmore; Joseph P Antoci; Ramon Perez-Marrero; Karny Jacoby; Ananias C Diokno; Keith J O'Reilly; Tomas L Griebling; Sandip P Vasavada; Albert S Yu; Lyn R Frumkin
Journal:  J Urol       Date:  2005-05       Impact factor: 7.450

Review 5.  Neuronal plasticity: increasing the gain in pain.

Authors:  C J Woolf; M W Salter
Journal:  Science       Date:  2000-06-09       Impact factor: 47.728

Review 6.  Bad bugs and beleaguered bladders: interplay between uropathogenic Escherichia coli and innate host defenses.

Authors:  M A Mulvey; J D Schilling; J J Martinez; S J Hultgren
Journal:  Proc Natl Acad Sci U S A       Date:  2000-08-01       Impact factor: 11.205

7.  Determination of mouse bladder inflammatory response to E. coli lipopolysaccharide.

Authors:  T J Jerde; D E Bjorling; H Steinberg; T Warner; R Saban
Journal:  Urol Res       Date:  2000-08

Review 8.  Susceptibility to acute pyelonephritis or asymptomatic bacteriuria: host-pathogen interaction in urinary tract infections.

Authors:  Bryndís Ragnarsdóttir; Catharina Svanborg
Journal:  Pediatr Nephrol       Date:  2012-02-12       Impact factor: 3.714

9.  O-antigen modulates infection-induced pain states.

Authors:  Charles N Rudick; Mingchen Jiang; Ryan E Yaggie; Vladimir I Pavlov; Joseph Done; Charles J Heckman; Christopher Whitfield; Anthony J Schaeffer; David J Klumpp
Journal:  PLoS One       Date:  2012-08-10       Impact factor: 3.240

10.  Mast cell-derived histamine mediates cystitis pain.

Authors:  Charles N Rudick; Paul J Bryce; Laura A Guichelaar; Ruth E Berry; David J Klumpp
Journal:  PLoS One       Date:  2008-05-07       Impact factor: 3.240

View more
  16 in total

Review 1.  Infection, Pain, and Itch.

Authors:  Isaac M Chiu
Journal:  Neurosci Bull       Date:  2017-01-31       Impact factor: 5.203

Review 2.  Questions and challenges associated with studying the microbiome of the urinary tract.

Authors:  Yige Bao; Kait F Al; Ryan M Chanyi; Samantha Whiteside; Malcom Dewar; Hassan Razvi; Gregor Reid; Jeremy P Burton
Journal:  Ann Transl Med       Date:  2017-01

Review 3.  Urologic chronic pelvic pain syndrome: insights from the MAPP Research Network.

Authors:  J Quentin Clemens; Chris Mullins; A Lenore Ackerman; Tamara Bavendam; Adrie van Bokhoven; Benjamin M Ellingson; Steven E Harte; Jason J Kutch; H Henry Lai; Katherine T Martucci; Robert Moldwin; Bruce D Naliboff; Michel A Pontari; Siobhan Sutcliffe; J Richard Landis
Journal:  Nat Rev Urol       Date:  2019-03       Impact factor: 14.432

4.  Bladder infection with uropathogenic Escherichia coli increases the excitability of afferent neurons.

Authors:  Nicolas Montalbetti; Marianela G Dalghi; Sheldon I Bastacky; Dennis R Clayton; Wily G Ruiz; Gerard Apodaca; Marcelo D Carattino
Journal:  Am J Physiol Renal Physiol       Date:  2021-11-15

5.  Acyloxyacyl hydrolase modulates pelvic pain severity.

Authors:  Wenbin Yang; Ryan E Yaggie; Mingchen C Jiang; Charles N Rudick; Joseph Done; Charles J Heckman; John M Rosen; Anthony J Schaeffer; David J Klumpp
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2017-11-08       Impact factor: 3.619

Review 6.  Role of neurogenic inflammation in local communication in the visceral mucosa.

Authors:  Lori A Birder; F Aura Kullmann
Journal:  Semin Immunopathol       Date:  2018-03-26       Impact factor: 9.623

7.  Staphylococcus aureus produces pain through pore-forming toxins and neuronal TRPV1 that is silenced by QX-314.

Authors:  Kimbria J Blake; Pankaj Baral; Tiphaine Voisin; Ashira Lubkin; Felipe Almeida Pinho-Ribeiro; Kelsey L Adams; David P Roberson; Yuxin C Ma; Michael Otto; Clifford J Woolf; Victor J Torres; Isaac M Chiu
Journal:  Nat Commun       Date:  2018-01-02       Impact factor: 14.919

Review 8.  From bladder to systemic syndrome: concept and treatment evolution of interstitial cystitis.

Authors:  Sara Dinis; Joana Tavares de Oliveira; Rui Pinto; Francisco Cruz; Ca Tony Buffington; Paulo Dinis
Journal:  Int J Womens Health       Date:  2015-07-23

Review 9.  Novel research approaches for interstitial cystitis/bladder pain syndrome: thinking beyond the bladder.

Authors:  Chris Mullins; Tamara Bavendam; Ziya Kirkali; John W Kusek
Journal:  Transl Androl Urol       Date:  2015-10

10.  The Therapeutic Effect of Human Embryonic Stem Cell-Derived Multipotent Mesenchymal Stem Cells on Chemical-Induced Cystitis in Rats.

Authors:  Sang Wook Lee; Chae-Min Ryu; Jung-Hyun Shin; Daeheon Choi; Aram Kim; Hwan Yeul Yu; Ju-Young Han; Hye-Yeon Lee; Jisun Lim; Yong Hwan Kim; Jinbeom Heo; Seungun Lee; Hyein Ju; Sujin Kim; Ki-Sung Hong; Ji-Yeon Han; Miho Song; Hyung-Min Chung; Jun Ki Kim; Dong-Myung Shin; Myung-Soo Choo
Journal:  Int Neurourol J       Date:  2018-01-31       Impact factor: 2.835

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.